Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku

article

Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5603/KP.2016.0141
P698PubMed publication ID27748494

P50authorVeli-Pekka HarjolaQ7918918
Piotr PonikowskiQ22114836
Stefan D. AnkerQ30310195
Ewa A JankowskaQ40395675
Volkmar FalkQ43778131
Mariell JessupQ51140498
Andrew CoatsQ51710454
Héctor BuenoQ56435517
Cecilia LindeQ56516163
Luis Miguel RuilopeQ56550076
Frans H RuttenQ57312328
Frank RuschitzkaQ63107473
Burkert PieskeQ79439304
Adriaan A VoorsQ91537232
Giuseppe RosanoQ96123790
Petros NihoyannopoulosQ114244144
Jillian P. RileyQ114321713
John T. ParissisQ114321802
José Ramón González JuanateyQ114410488
P2093author name stringJohn G.F. Cleland
Peter Van der Meer
P433issue10
P304page(s)1037-1147
P577publication date2016-10-13
P1433published inKardiologia PolskaQ2775982
P1476titleWytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku
P478volume74

Reverse relations

cites work (P2860)
Q649726302019 Focused Update of the Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure.
Q91712580An association between N-terminal pro-brain natriuretic protein level and risk of left ventricular hypertrophy in patients without heart failure
Q39032565Antiplatelet agents in hemodialysis.
Q97595055Assessment of diastolic dysfunction: comparison of different cardiovascular magnetic resonance techniques
Q61447932Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study
Q61812995Clinical and Rehabilitative Predictors of Peak Oxygen Uptake Following Cardiac Transplantation
Q58567579Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study
Q39641551Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.
Q33595504Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure
Q57180648Diagnosis of diastolic dysfunction in the emergency department: really at reach for minimally trained sonologists? A call for a wise approach to heart failure with preserved ejection fraction diagnosis in the ER
Q89588397Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting
Q55036577How to tackle congestion in acute heart failure.
Q64998433Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction.
Q90598385Non-Systematic Review of Diet and Nutritional Risk Factors of Cardiovascular Disease in Obesity
Q100995526Prognostic value of D-dimer in acute myocardial infarction complicated by heart failure with preserved ejection fraction
Q99630453Range of adiposity and cardiorenal syndrome
Q57214009The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea
Q94076951原发性和继发性扩张型心肌病患者心脏结构和功能发生逆转的相关因素
Q94076983急性心肌梗死早期脑钠肽浓度的动态演变规律及其对心力衰竭的诊断价值